1201643-69-7 Usage
Uses
Used in Organic Synthesis:
[1,2,4]Triazolo[1,5-a]pyridin-7-ylboronic acid is used as a reagent in organic synthesis for its ability to form stable covalent bonds with diols. This property allows it to participate in a wide range of chemical reactions, facilitating the creation of complex organic molecules.
Used in Suzuki Coupling Reactions:
In the field of cross-coupling reactions, [1,2,4]Triazolo[1,5-a]pyridin-7-ylboronic acid is utilized as a coupling partner in Suzuki reactions, a class of reactions that are widely used to form carbon-carbon bonds. Its participation in these reactions contributes to the synthesis of various organic compounds, including those with potential applications in material science and pharmaceuticals.
Used in Pharmaceutical and Agrochemical Synthesis:
[1,2,4]Triazolo[1,5-a]pyridin-7-ylboronic acid is used as a building block in the synthesis of pharmaceuticals and agrochemicals. Its unique structure and reactivity make it a valuable component in the development of new drugs and crop protection agents, potentially leading to the discovery of novel therapeutic agents and pesticides.
Used in Research and Development:
Due to its potential applications in organic synthesis and medicinal chemistry, [1,2,4]Triazolo[1,5-a]pyridin-7-ylboronic acid is also used in research and development settings. Scientists and chemists explore its properties and reactivity to further understand its potential uses and to develop new synthetic routes and applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1201643-69-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,6,4 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1201643-69:
(9*1)+(8*2)+(7*0)+(6*1)+(5*6)+(4*4)+(3*3)+(2*6)+(1*9)=107
107 % 10 = 7
So 1201643-69-7 is a valid CAS Registry Number.
1201643-69-7Relevant academic research and scientific papers
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORS
-
Page/Page column 133, (2010/01/12)
Provided are compounds according to Formula (I), or stereoisomer, prodrug, polymorph, or pharmaceutically acceptable salt forms thereof, wherein X, Y, R1, R6 , R7, and R8 are as defined, which compounds are effective inhibitors of PI3-kinase and/or other medically and clinically relevant kinases. Also provided are pharmaceutical compositions and methods of using the compounds and compositions as PB -kinase and kinase inhibitors. More particularly, the compounds of the invention provide treatments and therapeutics for human diseases regulated by, or associated with, the activity of, PI3-kinases and/or protein kinases, or mutant or variant forms thereof.
